Title 23 — Health and Safety
97 chapters · 659 sections in this title.
N.D.C.C. § 23-23.1-01 Use of laetrile authorized
0.8K chars
No hospital or health facility may interfere with the physician-patient relationship by restricting or forbidding the use of amygdalin when prescribed or administered by a licensed physician and requested by a patient unless the substance as prescribed or administered by the phys…
N.D.C.C. § 23-23.1-03 Hearing of board on effects of laetrile - Rules
0.2K chars
Any person may petition, or the board on its own motion may convene, a public hearing to determine the effects of the use of amygdalin and to promulgate rules and regulations pursuant to chapter 28-32 as to its use and administration.